Cargando…
Endothelial Dysfunction and Diabetic Cardiomyopathy
The cardiovascular complications contribute to a majority of diabetes associated morbidity and mortality, accounting for 44% of death in those patients with type 1 diabetes mellitus (DM) and 52% of deaths in type 2 DM. Diabetes elicits cardiovascular dysfunction through 2 major mechanisms: ischemic...
Autores principales: | Wang, Moran, Li, Yongsheng, Li, Sheng, Lv, Jiagao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021409/ https://www.ncbi.nlm.nih.gov/pubmed/35464057 http://dx.doi.org/10.3389/fendo.2022.851941 |
Ejemplares similares
-
Myocardial protection of S-nitroso-L-cysteine in diabetic cardiomyopathy mice
por: Peng, Lulu, et al.
Publicado: (2022) -
Endothelial Dysfunction in Diabetic Retinopathy
por: Gui, Fu, et al.
Publicado: (2020) -
Spermine Regulates Immune and Signal Transduction Dysfunction in Diabetic Cardiomyopathy
por: Wei, Can, et al.
Publicado: (2022) -
Diabetic endothelial microangiopathy and pulmonary dysfunction
por: Zhang, Lanlan, et al.
Publicado: (2023) -
Ferroptosis: roles and molecular mechanisms in diabetic cardiomyopathy
por: Zhao, Yangting, et al.
Publicado: (2023)